Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Dan Spillane who wrote (578)	3/25/1999 1:56:00 PM
From: Mike McFarland	Respond to of 1298

Seems like CEGE bottomed out around 4 1/2 after that slide from 7. And with news items such as this...well, why not get some? Cell Genesys Reports Efficient Gene Transfer to Bone Marrow Stem Cells With Lentiviral Gene Therapy Technology First Report of Stem Cell Gene Delivery at Potential Therapeutic Levels biz.yahoo.com I'm in for 1000 shares. Don't know if this was anticipated--but if I'm going to be a gene therapy freak, I might as well own this too. I see TGEN is down 1 1/2 right now, I'd say that is a buy as well. --MM

To: Dan Spillane who wrote (578)	4/2/1999 7:31:00 PM
From: Mike McFarland	Read Replies (1) \| Respond to of 1298

Too bad the cege reversal didn't last, maybe next week will see the sector liven up a bit. I sent my cege cash back into sibi, cant own all the gene therapy stocks out there, just the ones that seem to have bottomed out. fyi...That article you posted in #575 mentioned CLTX...it ran up quite a bit yesterday. Something to look at...folks will be putting their angiogenesis lists together this weekend to get ready for 60- minutes and the Sugen effect spilling over to other issues....